Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM StudyLudwig Kappos, Till Sprenger, Magdalena Pirozek-Lawniczek et al.|JAMA Neurology|2021Cited by 218